Patents by Inventor Louis F. Fries

Louis F. Fries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROTEOSOME INFLUENZA VACCINE
    Publication number: 20080260781
    Abstract: Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza HA as the antigen are used for illustration as to demonstrate efficacy. Improvements in the preparation of the vaccines themselves and the proteosome component are also included.
    Type: Application
    Filed: June 24, 2008
    Publication date: October 23, 2008
    Inventors: David S. Burt, David Hugh Jones, George H. Lowell, Gregory Leo White, Kirkor Torossian, Louis F. Fries, Martin Plante
  • Proteosome influenza vaccine
    Patent number: 7399840
    Abstract: Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza HA as the antigen are used for illustration as to demonstrate efficacy. Improvements in the preparation of the vaccines themselves and the proteosome component are also included.
    Type: Grant
    Filed: February 3, 2004
    Date of Patent: July 15, 2008
    Assignee: ID Biomedical Corporation of Quebec
    Inventors: David S. Burt, David H. Jones, George H. Lowell, Gregory L. White, Kirkor Torossian, Louis F. Fries, III, Martin Plante
  • Proteosome influenza vaccine
    Publication number: 20040156867
    Abstract: Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza HA as the antigen are used for illustration as to demonstrate efficacy. Improvements in the preparation of the vaccines themselves and the proteosome component are also included.
    Type: Application
    Filed: February 3, 2004
    Publication date: August 12, 2004
    Applicant: ID Biomedical Corporation of Quebec
    Inventors: David S. Burt, David Hugh Jones, George H. Lowell, Gregory Leo White, Kirkor Torossian, Louis F. Fries, Martin Plante
  • Proteosome influenza vaccine
    Patent number: 6743900
    Abstract: Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza HA as the antigen are used for illustration as to demonstrate efficacy. Improvements in the preparation of the vaccines themselves and the proteosome component are also included.
    Type: Grant
    Filed: February 15, 2001
    Date of Patent: June 1, 2004
    Assignee: ID Biomedical Corporation of Quebec
    Inventors: David S. Burt, David Hugh Jones, George H. Lowell, Gregory Lee White, Kirkor Torossian, Louis F. Fries, III, Martin Plante
  • Proteosome influenza vaccine
    Publication number: 20010053368
    Abstract: Improved forms of vaccines which comprise proteosomes and protein antigens are described. Vaccines which contain influenza HA as the antigen are used for illustration as to demonstrate efficacy. Improvements in the preparation of the vaccines themselves and the proteosome component are also included.
    Type: Application
    Filed: February 15, 2001
    Publication date: December 20, 2001
    Inventors: Davis S. Burt, David Hugh Jones, George H. Lowell, Gregory Lee White, Kirkor Torossian, Louis F. Fries, Martin Plante
  • Process for the purification of C1-inhibitor
    Patent number: 5030578
    Abstract: C1-inhibitor (C1-Inh), the major regulatory protein of the classical pathway of complement activation, can be purified in a new, simplied three step procedure which includes PEG fractionation, jacalin-agarose chromatography and hydrophobic interaction chromatography on phenyl-Sepharose which takes advantage of the marked hydrophilicity of the inhibitor. This procedure has major advantages over those which have been the most frequently used. This method may be highly adaptable to bulk purification for clinical use or for performing analytical or functional studies on genetically or pathologically altered C1-Inh from clinical specimens.
    Type: Grant
    Filed: July 10, 1989
    Date of Patent: July 9, 1991
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Yannick M. Pilatte, Carl H. Hammer, Michael M. Frank, Louis F. Fries